Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2000 R21 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2002 R33 PAR-01-104 LI, HONGHUA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH A GENETIC APPROACH TO GENOME-SCALE ANALYSIS OF CANCERS Complete
2005 R21 RFA-CA-05-003 KANDEL, EUGENE S CLEVELAND CLINIC LERNER COL/MED-CWRU REVERSIBLE PROMOTER-INSERTION FOR IN VIVO STUDIES OF MELANOMA Complete
2008 R21 RFA-CA-07-035 BARBAS, CARLOS F SCRIPPS RESEARCH INSTITUTE ZINC FINGER RECOMBINASES FOR ENDOGENOUS GENOME TAILORING Complete
2011 R21 RFA-CA-10-005 SANTANGELO, PHILIP J GEORGIA INSTITUTE OF TECHNOLOGY CHARACTERIZING GENE REGULATION WITH SINGLE MOLECULE SENSITIVE PROBES Complete
2015 R21 RFA-CA-14-005 SOHN, LYDIA L UNIVERSITY OF CALIFORNIA BERKELEY ISOLATING CIRCULATING TUMOR CELLS Complete
1999 R43 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2007 R33 RFA-CA-07-002 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON CHEMICAL CYTOMETRY FOR NEOPLASIA PROGNOSIS-BARRETT'S ESOPHAGUS Complete
2010 R21 RFA-CA-09-008 JI, HANLEE P STANFORD UNIVERSITY MUTATION ANALYSIS OF PARAFFIN-EMBEDDED TUMORS WITH NEXT GENERATION SEQUENCING Complete
2014 R33 RFA-CA-13-002 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2001 R33 PAR-98-067 ENGELWARD, BEVIN P. MASSACHUSETTS INSTITUTE OF TECHNOLOGY FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE Complete
2003 R41 PAR-01-105 GUTHOLD, MARTIN NANOMEDICA, INC. NOVEL, SINGLE-MOLECULE APTAMER SELECTION METHOD Complete
2007 R21 RFA-CA-07-001 STEINMAN, RICHARD A UNIVERSITY OF PITTSBURGH AT PITTSBURGH A NUCLEOSOMAL BIOSENSOR FOR IDENTIFICATION AND ISOLATION OF NUCLEAR HORMONE RECEP Complete
2009 R33 RFA-CA-08-008 ELLEDGE, STEPHEN J BRIGHAM AND WOMEN'S HOSPITAL A MULTIPLEX GENOME-WIDE SHRNA SCREENING PLATFORM FOR CANCER-LETHAL GENE DISCOVERY Complete
2009 R42 RFA-CA-08-012 GORBOVITSKI, BORIS ADVANCED BIOMEDICAL MACHINES, INC. DATA ACQUISITION SYSTEM FOR MULTIPLEX ANALYSIS OF COLOR ENCODED PARTICLES Complete
2013 R33 RFA-CA-12-003 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER ADVANCED DEVELOPMENT OF IMMUNO-MRM TECHNOLOGY TO ANALYZE ARCHIVED CANCER TISSUES Complete
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2000 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2002 R43 PAR-01-105 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. RAPID MOLECULAR DETECTION OF PML/RARALPHA Complete
2006 R21 RFA-CA-06-003 CREWS, CRAIG M YALE UNIVERSITY ANALYSIS OF TUMORIGENIC SIGNALING PATHWAYS WITH PROTACS Complete
2009 R21 RFA-CA-08-006 KRON, STEPHEN J. UNIVERSITY OF CHICAGO IMAGING DNA DAMAGE DYNAMICS FOR DIAGNOSTICS, SCREENING AND TARGET DISCOVERY Complete
2012 R21 RFA-CA-12-004 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA DEVELOPMENT OF ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2000 R21 PAR-99-100 CHURCHILL, GARY A JACKSON LABORATORY EXPERIMENTAL DESIGN & ANALYSIS FOR EXPRESSION MICROARRAY Complete
2002 R33 PAR-01-104 BEACHY, PHILIP A JOHNS HOPKINS UNIVERSITY GENOME-BASED TARGETING OF THE HEDGEHOG PATHWAY IN CANCER Complete
2005 R21 RFA-CA-05-004 GASTON, SANDRA MARLENE BETH ISRAEL DEACONESS MEDICAL CENTER TISSUE PRINT MICROPEELS FOR MOLECULAR PROFILING CANCER Complete
2008 R21 RFA-CA-07-035 LU, HANG GEORGIA INSTITUTE OF TECHNOLOGY MICROFLUIDIC SYSTEM FOR HIGH-THROUGHPUT EVALUATION OF T CELL FUNCTIONALITY WITH H Complete
2011 R21 RFA-CA-10-005 STRAUSS, STEVEN H. COLORADO STATE UNIVERSITY NANOCAGED METAL TAGS IN MASSIVELY MULTIPLEXED LEUKEMIA BIOASSAY AND BEYOND Complete
2015 R21 RFA-CA-14-005 QIN, LIDONG METHODIST HOSPITAL RESEARCH INSTITUTE HIGH THROUGHPUT SINGLE-CELL PHENOTYPE ISOLATION BY PROTRUSION ANALYSIS CHIP (PAC) Complete
1999 R43 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2007 R33 RFA-CA-07-016 MACBEATH, GAVIN HARVARD UNIVERSITY QUANTITATIVE INTERACTION NETWORKS FOR TYROSINE-PHOSPHORYLATED PROTEINS Complete
2010 R21 RFA-CA-09-008 MITRA, ROBI D WASHINGTON UNIVERSITY HIGHLY PARALLEL EDMAN SEQUENCING OF INDIVIDUAL PEPTIDE MOLECULES Complete
2014 R33 RFA-CA-13-002 LOEB, LAWRENCE A UNIVERSITY OF WASHINGTON VALIDATION AND ADVANCED DEVELOPMENT OF DUPLEX SEQUENCING Complete
2001 R33 PAR-98-067 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE TECHNOLOGY FOR MUTATION ANALYSIS OF CANCER Complete
2003 R43 PAR-01-105 SHEN, LI SUPERARRAY BIOSCIENCE CORPORATION ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT Complete
2007 R21 RFA-CA-07-001 LINK, DARREN R RAINDANCE TECHNOLOGIES, INC. EXON SPECIFIC SEQUENCING OF WHOLE GENOMIC DNA Complete
2003 R43 PAR-01-105 DIATCHENKO, LUDA ATTAGENE, INC. PROFILING OF SIGNAL TRANSDUCTION PATHWAYS IN CANCER Complete
2007 R21 RFA-CA-07-002 XU, XIAOWEI UNIVERSITY OF PENNSYLVANIA ULTRASENSITIVE FACTT ASSAYS FOR SERUM BIOMARKERS Complete
2009 R43 RFA-CA-08-011 ZWICK, MICHAEL G ANDROBIOSYS, INC. PRIMARY XENOGRAFTS OF HUMAN TISSUE AS SURROGATES OF CANCER IN SITU Complete
2013 R33 RFA-CA-12-003 TACKETT, ALAN JACKSON UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT OF MASSSQUIRM TO QUANTITATIVELY MEASURE LYSINE METHYLATION Complete
2016 R33 RFA-CA-15-003 LAM, KIT S UNIVERSITY OF CALIFORNIA AT DAVIS GESI: a novel technology for functional imaging in living cells Complete
2000 R43 PAR-98-066 BOGEN, STEVEN A CYTOLOGIX CORPORATION INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS Complete
2002 R43 PAR-01-105 YANG, XING GENEOHM SCIENCES, INC. MULTIPLEXED DNA-MEDIATED ELECTOCHEMICAL SENSORS Complete
2006 R21 RFA-CA-06-003 HAAB, BRIAN B. VAN ANDEL RESEARCH INSTITUTE DEFINING SECRETED GLYCAN ALTERATIONS IN PANCREATIC CANCER Complete
2009 R21 RFA-CA-08-006 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY DEVELOPING A SINGLE CELL GROWTH MONITOR FOR CLASSIFYING THERAPEUTIC RESPONSE Complete
2012 R33 RFA-CA-12-003 ZU, YOULI METHODIST HOSPITAL RESEARCH INSTITUTE ACTIVATABLE ONE-DROP AND ONE-STEP ASSAY FOR CIRCULATING TUMOR CE Complete
2016 R21 RFA-CA-15-002 HELD, JASON M. WASHINGTON UNIVERSITY DEVELOPMENT OF NOVEL CHEMICAL PROBES TO MAP S-NITROSYLATION IN CANCER Complete

Pages